Coronavirus Vaccines Reached to EU Countries
Coronavirus vaccines reached to EU countries.
EU Commission President Ursula von der Leyen announced with a video message that the vaccines have been received.
The coronavirus vaccines developed by BioNTech and Pfizer for use in the treatment of coronavirus were delivered to all European Union countries.
EU member countries will start vaccinations from tomorrow.
“We're starting to turn a new page in a difficult year.” In her statement, von der Leyen stated that the deliveries have been made and that tomorrow healthcare professionals will start vaccinating across Europe.
Stating that all
EU countries have access to the vaccine at the same time, von der Leyen noted that more vaccines will be introduced in a short time and that life will gradually return to normal.
The European Medicines Agency (EMA), the European Union's drug regulator, approved the use of the BioNTech / Pfizer vaccine in the EU. EMA's evaluations for the coronavirus vaccine of American drug manufacturer Moderna are still ongoing. It is predicted that the EMA will make its decision on this vaccine in the first week of January.
The EU Commission has not made a statement about how many doses of vaccine has been sent to its members and how much vaccine has been sent to which country. However, for now, it is stated that the number of doses is very low due to the limitations in production capacity.
On the other hand, the European Union signed a contract with 6 companies to purchase a total of 2 million doses of vaccine. Accordingly, the Union will be able to receive 400 million doses of vaccine from AstraZeneca, 300 million from Sanofi-GSK, 400 million from Johnson and Johnson, 300 million from Pfizer and BioNTech, 405 million from CureVac and 160 million from Moderna.
With Novavax, the contract phase has been reached for the purchase of 200 million doses of vaccine. With the conclusion of this contract with the signature, the amount that the
EU can receive will approach 2.2 billion.
EU member countries run their own vaccine campaigns. Each country determines who will be given priority for vaccination.